ReviewArteriosclerosis, thrombosis, and vascular biology2026
Enabling Technologies in Vascular Biology: Microphysiological Systems, Organoids, and Beyond.
Review in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Vascular and cardiovascular diseases are leading causes of mortality globally. Despite significant progress in elucidating the molecular and cellular mechanisms involved in these conditions, some critical aspects, including complex intercellular interactions and therapeutic efficacy, require further investigation to be fully understood and predicted. This lack of knowledge motivates the development of advanced research methodologies, where bioengineering has contributed significantly. Technological advances in bioengineering have evolved into powerful tools that replicate the molecular and cellular microenvironment of human vascular and cardiac tissues with unprecedented fidelity in vitro and ex vivo. The evolution of conventional 2-dimensional, monocultured cell models into 3-dimensional and mechanically dynamic models that also possess tissue-level cellular and molecular sophistications enables studying vascular pathologies and therapies with promising predictability. Various techniques, such as microphysiological systems, organoids, and bioprinting, are increasingly used and further improved through numerous studies to reconstruct human vascular microenvironment and the associated diseases such as atherosclerosis and thrombosis in vitro. Despite these advancements, there are still challenges with each of these methods in addition to the knowledge gaps left for future research. This review takes a critical approach to comprehensively review existing reports and the most recent progress in the application of cutting-edge in vitro and ex vivo technologies for vascular biology and pathology. More importantly, it highlights the challenges and research gaps that will require future research to be addressed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.